| Placebo (n = 16) | Fluvoxamine (n = 17) | P-value | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Day 14 | Day 42 | Day 70 | Day 14 | Day 42 | Day 70 | Day 14 | Day 42 | Day 70 |
VAS Fatigue | -1.3 | -0.6 | -0.55 | -0.3 | -0.4 | -0.35 | 0.31 | 0.51 | 0.51 |
FFSS | |||||||||
   Physical Domain | -2.0 | -3.5 | -4.0 | 0 | -2.5 | 0 | 0.31 | 0.40 | 0.12 |
   Cognitive Domain | -1.5 | 1.0 | 0 | -1.0 | -1.0 | 0 | 0.69 | 0.85 | 0.60 |
   Social Domain | -3.0 | -3.5 | -2.0 | -3.0 | -4.0 | -1.5 | 0.66 | 0.93 | 0.93 |
MFI | |||||||||
   General Fatigue | -2.0 | 0 | 0 | 0 | 0 | -1.0 | 0.10 | 0.62 | 0.87 |
   Physical Fatigue | 0 | 0 | 0 | 0 | 1.0 | 1.0 | 0.92 | 0.73 | 0.44 |
   Reduction Activity | 0.5 | -1.0 | 0 | 1.0 | -0.5 | 1.0 | 0.20 | 0.56 | 0.13 |
   Reduction Motivation | -1.0 | 0 | -1.0 | 1.0 | -0.5 | 1.0 | 0.08 | 0.94 | 0.71 |
   Mental Fatigue | -1.0 | -0.5 | 0 | 0 | 0 | 0 | 0.06 | 0.35 | 0.89 |